Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer of the Bile Duct”

349 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 349 results

Not applicableUnknownNCT06115655
What this trial is testing

A Single-center, Prospective Cohort Study on the Differentiation of Benign and Malignant Bile Duct Stenosis Based on Bile and Peripheral Blood cfDNA Methylation Profiles

Who this might be right for
Bile Duct NeoplasmsJaundice, ObstructiveBile Duct Diseases
Air Force Military Medical University, China 161
Early research (Phase 1)UnknownNCT02042859
What this trial is testing

Radiofrequency Probe for Management of Unresectable Bile Duct and Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Ochsner Health System 40
Early research (Phase 1)Study completedNCT02451553
What this trial is testing

Afatinib Dimaleate and Capecitabine in Treating Patients With Advanced Refractory Solid Tumors, Pancreatic Cancer or Biliary Cancer

Who this might be right for
Advanced Malignant Solid NeoplasmBile Duct CarcinomaRecurrent Malignant Solid Neoplasm+4 more
University of Washington 41
Early research (Phase 1)Study completedNCT00003439
What this trial is testing

Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 36
Large-scale testing (Phase 3)Study completedNCT00262769
What this trial is testing

Gemcitabine With or Without Cisplatin in Treating Patients With Unresectable Locally Advanced or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder Cancer
University College, London 324
Large-scale testing (Phase 3)Study completedNCT00016380
What this trial is testing

Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen

Who this might be right for
Cancer
NCIC Clinical Trials Group 211
Not applicableEnded earlyNCT03137706
What this trial is testing

Characterization of Mechanical Tissue Properties in Patients With Pancreatic, Liver, or Colon Cancer

Who this might be right for
Colon CarcinomaLiver and Intrahepatic Bile Duct CarcinomaPancreatic Carcinoma
University of Southern California 8
Testing effectiveness (Phase 2)Study completedNCT00075504
What this trial is testing

Triapine and Gemcitabine Hydrochloride in Gallbladder Cancer

Who this might be right for
Stage II Gallbladder CancerStage IIIA Gallbladder CancerStage IIIB Gallbladder Cancer+2 more
National Cancer Institute (NCI) 33
Testing effectiveness (Phase 2)Study completedNCT00021047
What this trial is testing

Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor

Who this might be right for
Esophageal CancerExtrahepatic Bile Duct CancerGastric Cancer+3 more
National Institutes of Health Clinical Center (CC)
Not applicableStudy completedNCT05266300
What this trial is testing

Implementation and Quality Assurance of DPYD-genotyping in Patients Treated With Fluoropyrimidines.

Who this might be right for
Adverse Drug EventColon CancerBreast Cancer+5 more
University of Southern Denmark 722
Not applicableUnknownNCT05706974
What this trial is testing

Looking At Bile Duct Cancer Patient Experience Patterns in Medical Trials

Who this might be right for
Bile Duct Cancer
Power Life Sciences Inc. 500
Testing effectiveness (Phase 2)Study completedNCT00553332
What this trial is testing

Selumetinib in Treating Patients With Biliary Cancer That Cannot Be Removed By Surgery

Who this might be right for
Liver and Intrahepatic Biliary Tract CancerRecurrent Extrahepatic Bile Duct CancerUnresectable Extrahepatic Bile Duct Cancer
National Cancer Institute (NCI) 29
Early research (Phase 1)Study completedNCT04164069
What this trial is testing

Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab

Who this might be right for
Advanced Colorectal CarcinomaMetastatic Colorectal CarcinomaStage IV Colorectal Cancer AJCC v8+13 more
Anne Noonan 9
Not applicableLooking for participantsNCT06711211
What this trial is testing

Spanish Registry of Digestive Tumours RETUD

Who this might be right for
Digestive CancersBile Duct CancerHepatocellular Cancer (HCC)+3 more
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) 20,000
Not applicableLooking for participantsNCT04037007
What this trial is testing

Efficacy of Fistulotomy for Biliary Cannulation

Who this might be right for
CholangiocarcinomaCholedocholithiasis; CholangitisPancreatic Cancer+1 more
Coordinación de Investigación en Salud, Mexico 320
Early research (Phase 1)UnknownNCT04660929
What this trial is testing

CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors

Who this might be right for
HER2-positiveAdenocarcinomaBile Duct Cancer+28 more
Carisma Therapeutics Inc 48
Testing effectiveness (Phase 2)Looking for participantsNCT05150691
What this trial is testing

A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors

Who this might be right for
HER2-positive Advanced Solid Tumor
DualityBio Inc. 796
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Who this might be right for
Acinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more
National Cancer Institute (NCI) 798
Not applicableEnded earlyNCT00087191
What this trial is testing

EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer

Who this might be right for
Advanced Adult Primary Liver CancerCarcinoma of the AppendixFallopian Tube Cancer+68 more
National Cancer Institute (NCI) 30
Not applicableStudy completedNCT05429203
What this trial is testing

Comparison of Duodenoscope With Single-use Distal Cover and the Conventional Reusable Duodenoscope

Who this might be right for
Biliary DiseasePancreatic DiseaseCholedocholithiasis+3 more
Stanford University 319
Load More Results